https://www.live-feeds.com/feed/j-j-orthopedics-unit-draws-apollo-interest-in-potential-20-billion-deal-bloomberg-news-reportsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/j-j-orthopedics-unit-draws-apollo-interest-in-potential-20-billion-deal-bloomberg-news-reportshttps://www.live-feeds.com/feed/j-j-orthopedics-unit-draws-apollo-interest-in-potential-20-billion-deal-bloomberg-news-reports#u69933Wed, 16 Sep 2026 06:50:50 +0000Apollo Global Management is negotiating to purchase DePuy Synthes, the orthopedics business of Johnson & Johnson, in a deal potentially valued at nearly $20 billion. The unit produced $9.3 billion in revenue in 2025. While Apollo is the primary suitor, the business could alternatively be spun off as a public company. J&J shares rose 1.3% to $268.96 in premarket trading on Monday following the reports. Neither company has signed a binding agreement, but sources suggest a definitive deal could be reached within several weeks.Why it mattersDePuy Synthes specializes in hip and knee replace https://www.live-feeds.com/feed/j-j-orthopedics-unit-draws-apollo-interest-in-potential-20-billion-deal-bloomberg-news-reportshttps://www.live-feeds.com/feed/j-j-orthopedics-unit-draws-apollo-interest-in-potential-20-billion-deal-bloomberg-news-reports#u67087Sun, 13 Sep 2026 15:26:21 +0000Johnson & Johnson is currently in negotiations to sell its hips-and-knees orthopedics business to Apollo Global Management in a potential $20 billion transaction. This development follows initial reports from Bloomberg News regarding the possible multi-billion-dollar deal. Stock for Johnson & Johnson edged up in after-hours trading following the reports of the ongoing acquisition talks. The transaction would transfer a major medical device division to the private equity firm, though neither company has formally finalized or announced a binding agreement.Why it mattersJohnson & John